Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

7th Eurasian Hematology Oncology Summit
Avatar

How I Treat Frontline ALL in 2020: Does Ph-Like Disease Have a Higher MRD+ Rate? Is ChemoRx+/- Rituximab Beneficial for OS/EFS in Burkitt Disease? Do We Need AlloSCT?

By 7th Eurasian Hematology Oncology Summit FEATURING Hagop Kantarjian
By 7th Eurasian Hematology Oncology Summit FEATURING Hagop Kantarjian
28 views
December 11, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

15:58
Amgen Hematology

Insights on Proteasome Inhibitor Combinations at First Relapse in Mu…

Feat. M. Levy
Leukemia
07:30

Rational Drug Use for Hematologic Malignancies: How Do We Define It?…

7th Eurasian Hematology Oncology Summit

M. Yilmaz

17 views
14:53

2020 Updates on MRD in Adult ALL: How Does MRD Help With the Assessm…

7th Eurasian Hematology Oncology Summit

F. Ravandi

12 views
12:22

2020 Updates on Frontline AML: Does Midostaurin+Chemo Reduce the Ris…

7th Eurasian Hematology Oncology Summit

G. Martinelli

19 views
23:15

2020 Frontline CML Update: Comparing TKI Inhibitors, Achieving TFR i…

7th Eurasian Hematology Oncology Summit

G. Saglio

91 views
15:13

How I Treat Frontline CML in 2020: Does Imatinib Improve Long-Term S…

7th Eurasian Hematology Oncology Summit

H. Kantarjian

480 views
14:55

How I Treat Frontline ALL in 2020: Does Ph-Like Disease Have a Highe…

7th Eurasian Hematology Oncology Summit

H. Kantarjian

28 views
17:21

2020 Update on MRD in AML: Does Decitabine Prolong RFS/OS in Newly D…

7th Eurasian Hematology Oncology Summit

F. Ravandi

12 views
14:41

How I Treat AML in 2020: Is Addition of Azacitidine to Venetoclax/Pl…

7th Eurasian Hematology Oncology Summit

F. Ravandi

522 views
21:52

2020 Efficacy Data on Targeted Therapies in CLL: Do We Need to Combi…

7th Eurasian Hematology Oncology Summit

P. Panayiotidis

85 views
18:04

How I Treat CLL in 2020: How Do Ibrutinib/Rituximab & Venetoclax/Obi…

7th Eurasian Hematology Oncology Summit

R. Foa

200 views